Filing
4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$450,000.00
What this organization spent lobbying with its own staff.
Reported using A: the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
District of Columbia
Lobbyists on this filing
1
-
SHARA SIEGEL New on this filingPreviously held: Food and Drug Administration, Public Health Advisor (March 2024-June 2025)
Government bodies contacted
2
Lobbying activity
2
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices.
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices.